Research Interests
Currently funded studies include the following interests:
1-Spontaneous humoral anti-tumor immunity, including the formation of Tertiary Lymphoid Structures
2-Novel antibody-based immunotherapies
3-Crosstalk between butyrophilins and gamma/delta T cells in human cancer
4-Dark matter, unconventional cancer antigens
5-Empowering CAR T cells to become effective in epithelial tumors
6-T cell lymphoma
1-Spontaneous humoral anti-tumor immunity, including the formation of Tertiary Lymphoid Structures
2-Novel antibody-based immunotherapies
3-Crosstalk between butyrophilins and gamma/delta T cells in human cancer
4-Dark matter, unconventional cancer antigens
5-Empowering CAR T cells to become effective in epithelial tumors
6-T cell lymphoma
Selected Grants
Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028OR2H1 is an effective target for CAR T cells in human epithelial tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025Olfactory receptor OR2H1 as an effective target for CAR T cells in human epithelial tumors
ResearchPrincipal Investigator · Awarded by Cancer Research Institute · 2023 - 2024Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024B cell-dependent anti-tumor immunity in ovarian cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024External Relationships
- Alloy Therapeutics
- Anixa Biosciences
- Compass Therapeutics
- Mays Cancer Center at UT San Antonio
- National Cancer Institute
- Alloy Therapeutics
- Anixa Biosciences
- Compass Therapeutics
- Mays Cancer Center at UT San Antonio
- National Cancer Institute
- University of Pittsburgh Spore in ovarian cancer
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.